/ /

Contemporary OB/GYN Staff
Peanut butter linked to lower risk of breast disease
Teens who eat peanut butter and other nuts may be at lower risk of benign breast disease (BBD) as adults, according to a new report published in Breast Cancer Research and Treatment.
Robotics may not improve hysterectomy outcomes
A new retrospective study published in Obstetrics & Gynecology shows that robotics don’t improve benign hysterectomy outcomes and, in fact, increase cost of the surgery.
Does HRT raise risk of breast cancer in thin or obese women?
A new registry-based study sheds light on patient factors that may influence risk of breast cancer associated with use of postmenopausal hormone replacement therapy (HRT)—including race, weight, and breast density. Findings from the report, published in The Journal of the National Cancer Institute, suggest the greatest association between HRT use and breast cancer in women with low/normal body mass index (BMI) and extremely dense breasts.
USPSTF updates guidelines on medication for breast cancer risk reduction
In an update of its 2002 recommendation on use of medications for breast cancer risk reduction, the U.S. Preventive Services Task Force (USPSTF) is encouraging informed decision-making and cautioning against use of medications for prevention in women who are not at increased risk of the disease.
Women who don’t get mammograms most likely to die of breast cancer
A new multicenter analysis shows that most deaths from invasive breast cancer occur in women who don’t get routine mammograms. The findings, published in Cancer, point to a need to encourage routine screening in women younger than age 50.
FDA prepares to approve Perjeta for use pre-surgery
The Food and Drug Administration’s (FDA) advisory committee cleared the way for the approval of pertuzumab (Perjeta) to treat patients before they have surgery to remove their HER2-positive tumors. If approved, pertuzumab would be the first neoadjuvant drug approval for any form of cancer. The drug was already approved by the FDA for treatment of late-stage breast cancer last year.
Alcohol consumption doesn't lead to pregnancy complications
Expectant mothers might not need to worry about a glass of wine, according to new research published in Obstetrics & Gynecology.
Investigational fertility treatment approved by FDA
The US Food and Drug Administration approved the new drug application (NDA) for Merck’s investigational fertility treatment corifollitropin alfa. Merck is seeking approval for the use of corifollitropin alfa in controlled ovarian stimulation (COS). If approved, the drug would be the first sustained follicular stimulant available in the United States.
Life expectancy on the rise for older women
Recent findings by the World Health Organization (WHO) show that around the world, life expectancy for women over age 50 is still increasing.
Medicaid pays for nearly half of all US births
In 2010, Medicaid financed 48% of all births in the United States, an increase of 19% in the proportion of all births covered by Medicaid in 2008. This finding, from a study published in the Sept. 2013 issue of the journal Women's Health Issues, adds to previous research showing that the numbers of women dependent on Medicaid for health care are growing.